Hovione

Delox is a Portuguese company focused on the design and development of bio-decontamination devices aimed at creating clean and biosafe environments. Founded in 2018 as a spin-off from the Faculty of Sciences of the University of Lisbon, Delox specializes in automatic bio-decontamination robots and has developed a proprietary solid formulation of hydrogen peroxide, known as DeloxHP. This innovation allows for the efficient production of compact and cost-effective bio-decontamination devices, including the Delox Box, which is ready for market use. The company’s technology is applicable in various sectors, including the sterilization of medical devices, room bio-decontamination in hospitals and the food industry, as well as the decontamination of laboratory equipment and environmental test chambers. Delox aims to provide non-toxic solutions that effectively combat microorganisms, catering to the health, pharmaceutical, biodefense, and space industries.

CellmAbs, established in 2019 and headquartered in Lisbon, Portugal, specializes in developing therapies for glycoimmunology and oncology. As a spin-off from NOVA University of Lisbon, the company focuses on creating solutions for cancer treatment, immunotherapies, and glycobiology. CellmAbs has swiftly grown into an internationally experienced team, having produced several preclinical candidates targeting solid tumors by leveraging advanced knowledge of cancer-specific glycan targets.

CellmAbs, established in 2019 and headquartered in Lisbon, Portugal, specializes in developing therapies for glycoimmunology and oncology. As a spin-off from NOVA University of Lisbon, the company focuses on creating solutions for cancer treatment, immunotherapies, and glycobiology. CellmAbs has swiftly grown into an internationally experienced team, having produced several preclinical candidates targeting solid tumors by leveraging advanced knowledge of cancer-specific glycan targets.

Delox is a Portuguese company focused on the design and development of bio-decontamination devices aimed at creating clean and biosafe environments. Founded in 2018 as a spin-off from the Faculty of Sciences of the University of Lisbon, Delox specializes in automatic bio-decontamination robots and has developed a proprietary solid formulation of hydrogen peroxide, known as DeloxHP. This innovation allows for the efficient production of compact and cost-effective bio-decontamination devices, including the Delox Box, which is ready for market use. The company’s technology is applicable in various sectors, including the sterilization of medical devices, room bio-decontamination in hospitals and the food industry, as well as the decontamination of laboratory equipment and environmental test chambers. Delox aims to provide non-toxic solutions that effectively combat microorganisms, catering to the health, pharmaceutical, biodefense, and space industries.